NEW YORK (GenomeWeb News) – Bioinformatics firm Maverix Biomics today announced it raised $6 million in a Series A financing round to support the continued commercialization of its recently launched data analysis platform.

The financing was led by Asset Management Ventures and individual investors Andreas Bechtolsheim and Andrew Yang. In conjunction with the financing, Yang and Louis Lange, a general partner at Asset Management, have joined Maverix's board.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

NPR reports that with medical data being big business, some companies want to get patients involved.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.